Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Thiel

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Nature Biotechnology|January 10, 2008
Shareholders flex their musclesKarl Thiel
Nature Biotechnology|June 4, 2004
Oligo oligarchy-the surprisingly small world of aptamersKarl Thiel
Nature Biotechnology|December 17, 2009
Biotechs get $1 billion windfall in R&D tax creditsKarl Thiel
Nature Biotechnology|September 12, 2006
Systems biology, incorporated?Karl Thiel
Nature Biotechnology|January 6, 2004
Old dogma, new tricks--21st Century phage therapyKarl Thiel
Nature Biotechnology|December 17, 2009
Congress punts on SBIR reauthorizationKarl Thiel
Leukemia & Lymphoma|August 19, 2007
White blood cell count nadir following remission induction chemotherapy is predictive of outcome in older adults with acute myeloid leukemiaHyo Sook Han, Lisa A Rybicki, Karl Thiel, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Nature Biotechnology|January 10, 2008
Shareholders flex their musclesKarl Thiel
Nature Biotechnology|June 4, 2004
Oligo oligarchy-the surprisingly small world of aptamersKarl Thiel
Nature Biotechnology|December 17, 2009
Biotechs get $1 billion windfall in R&D tax creditsKarl Thiel
Nature Biotechnology|September 12, 2006
Systems biology, incorporated?Karl Thiel
Nature Biotechnology|January 6, 2004
Old dogma, new tricks--21st Century phage therapyKarl Thiel
Nature Biotechnology|December 17, 2009
Congress punts on SBIR reauthorizationKarl Thiel
Leukemia & Lymphoma|August 19, 2007
White blood cell count nadir following remission induction chemotherapy is predictive of outcome in older adults with acute myeloid leukemiaHyo Sook Han, Lisa A Rybicki, Karl Thiel, et al.
Pageof 1